Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)
Clinical trial NCT01926015 · COMPLETED
Trial details
- NCT number
- NCT01926015
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-19
- Primary completion
- 2014-06-06
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.